Pillcheck: Optimizing Medication Plans for Seniors with Dementia

Pillcheck: Optimizing Medication Plans for Seniors with Dementia

Ruslan Dorfman, PhD, MBA19 janv. 2022

Centre for Aging + Brain Health Innovation (CABHI) study finds that Pillcheck helped identify medications that were not effective or posed a high risk of side effects for long-term care residents. The revised medication plans significantly improved the management of depression and chronic pain and reduced the risk of complications for many residents. Click the image below to read their summary.

Pillcheck: Optimizing Medication Plans for Seniors with Dementia - Centre for Aging + Brain Health Innovation https://www.cabhi.com/completed-project-summaries/pillcheck-optimizing-medication-plans-for-seniors-with-dementia/

 

For more detail on the study and findings, see https://pubmed.ncbi.nlm.nih.gov/32536434/.

Retour au blog

À propos de l'auteur

Ruslan Dorfman

Ruslan Dorfman

PhD, MBA

Founder and CSO Ruslan Dorfman is a trailblazer in personalized medicine, a molecular geneticist, and technology builder. Inspired by direct interactions with Cystic Fibrosis families from all over the world, Dr. Dorfman co-founded GeneYouIn to facilitate access to advanced genetics for the general public. He managed large-scale R&D programs at Sick Kids Hospital, Toronto. He advised Bridgepoint and Mount Sinai hospitals on the implementation of personalized medicine programs. Dr. Dorfman has published thirty peer-reviewed papers on the genetics of Cystic Fibrosis and Pain.